Insider NameBuy/SellCompany NameTickerAmountShares Change
Mar 04, 2024Mar 06, 2024McGlynn Margaret G
Dir
SellAmicus Therapeutics, Inc.FOLD$13.35$200,175-20.19%
Jan 13, 2023Jan 17, 2023McGlynn Margaret G
Dir
SellAmicus Therapeutics, Inc.FOLD$13.03$195,387-22.83%
May 02, 2022May 04, 2022McGlynn Margaret G
Dir
SellAmicus Therapeutics, Inc.FOLD$6.99$104,897-28.28%
Apr 08, 2022Apr 12, 2022McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$280.22$1M-81.98%
Mar 31, 2022Apr 04, 2022McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$262.27$1M-81.98%
Jan 28, 2022Feb 01, 2022McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$241.79$1M-81.98%
May 03, 2021May 05, 2021McGlynn Margaret G
Dir
SellAmicus Therapeutics, Inc.FOLD$10.27$102,704-26.37%
Apr 17, 2020Apr 20, 2020McGlynn Margaret G
Dir
SellAmicus Therapeutics, Inc.FOLD$11$110,000-31.19%
Jan 09, 2020Jan 10, 2020McGlynn Margaret G
Dir
SellAmicus Therapeutics, Inc.FOLD$10$200,000-47.55%
Oct 22, 2019Oct 24, 2019McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$190$4M-82.90%
Aug 13, 2019Aug 15, 2019McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$185$2M-70.80%
May 16, 2018May 18, 2018McGlynn Margaret G
Dir
SellAmicus Therapeutics IncFOLD$16$160,000-38.74%
Mar 02, 2018Mar 05, 2018McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$170$2M-61.30%
Jan 22, 2018Jan 24, 2018McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$162.5$3M-76.29%
Nov 18, 2015Nov 20, 2015McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$130.15$2M-91.99%
Nov 10, 2015Nov 10, 2015McGlynn Margaret G
Dir
BuyAmicus Therapeutics IncFOLD$10.27$102,657+50.00%
Aug 03, 2015Aug 05, 2015McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$137.28$2M-91.99%
Jun 01, 2015Jun 03, 2015McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$127.32$2M-91.99%
Apr 06, 2015Apr 08, 2015McGlynn Margaret G
Dir
SellVertex Pharmaceuticals Inc / MaVRTX$118.36$1M-91.99%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.